Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus

Journal of the American Academy of Dermatology

Volumn 49, Issue 2, 2003, Pages 276-280

  Cummins, Deborah L ^b   Mimouni, Daniel ^b   Anhalt, Grant J ^a   Nousari, Carlos H ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABDOMINAL PAIN; ARTICLE; BLADDER CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; FOLLOW UP; HEMATURIA; HUMAN; NAUSEA; PATIENT MONITORING; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; TRANSITIONAL CELL CARCINOMA;

EID: 0041632187     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00859-4     Document Type: Article

References (16)

1. Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris: a long-term follow up. J Am Acad Dermatol 1987;16:527-33.
2. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135:54-6.
3. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999;40:265-8.
4. Ahmed AR, Hombal S. Use of cyclophosphamide in azathioprine failures in pemphigus. J Am Acad Dermatol 1987;17:437-42.
5. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
6. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996;124:477-84.
7. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990;29:371-4.
8. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995;34:875-82.
9. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999;135:57-61.
10. Ebringer A, Mackay IR. Pemphigus vulgaris successfully treated with cyclophosphamide. Ann Intern Med 1969;71:125-7.
11. Glickman FS, Silvers SH. Pemphigus vulgaris treated with cyclophosphamide. Arch Dermatol 1973;107:467-8.
12. Krain LS, Landau JW, Newcomer VD. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1972;106:657-61.
13. McKelvey EM, Hasegawa J. Cyclophosphamide and pemphigus vulgaris. Arch Dermatol 1971;103:198-200.
14. Piamphongsant T, Ophaswongse S. Treatment of pemphigus. Int J Dermatol 1991;30:139-46.
15. Hietanen J, Salo OP. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm Venereol 1982;62:491-6.
16. Huilgol SC, Black MM. Management of the immunobullous disorder, II: pemphigus. Clin Exp Dermatol 1995;20:283-93.